Reaction Details Report a problem with these data
Target
N-formyl peptide receptor 2
Ligand
BDBM350531
Substrate
n/a
Meas. Tech.
FLIPR
EC50
166±n/a nM
Citation
 Viswanath, V; Beard, RL; Donello, JE; Hsia, E Use of agonists of formyl peptide receptor 2 for treating dermatological diseases US Patent  US10799518 Publication Date 10/13/2020 
Target
Name:
N-formyl peptide receptor 2
Synonyms:
ALXR, FPRL1, FPR2 | FMLP-related receptor I FMLP-R-I | FPR2 | FPR2_HUMAN | FPRH1 | FPRL1 | Formyl Peptide Receptor-Like 1 | HM63 | LXA4 receptor | LXA4R | Lipoxin A4 receptor | Lipoxin A4 receptor (LXA4) | RFP | hFPRL
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
38968.35
Organism:
Homo sapiens (Human)
Description:
P25090
Residue:
351
Sequence:
METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIALDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNFASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPLRVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPMLYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM
  
Inhibitor
Name:
BDBM350531
Synonyms:
N-(4-bromophenyl)-2-(4-cyclopropyl- 4-methyl-2,5-dioxoimidazolidin-1- yl)acetamide | US10208071, Table 3.7 | US10799518, Structure TABLE 3.7
Type:
Small organic molecule
Emp. Form.:
C15H16BrN3O3
Mol. Mass.:
366.21
SMILES:
CC1(NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O)C1CC1
Structure:
Search PDB for entries with ligand similarity: